T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection

Cancer Gene Therapy

Volumn 7, Issue 6, 2000, Pages 920-926

  Di Ianni, Mauro ^a   Di Florio, Sabrina ^a   Venditti, Gigliola ^a   Liberatore, Concetta ^a   Lucheroni, Francesca ^a   Falzetti, Franca ^a   Terenzi, Adelmo ^a   Stella, Carmelo Carlo ^b   Spinozzi, Fabrizio ^a   Mannoni, Patrice ^c   Martelli, Massimo F ^a   Tabilio, Antonio ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c INSTITUT PAOLI CALMETTES   (France)

Author keywords

Gene transfer; Limiting dilution assay; T lymphocytes; Thymidine kinase

Indexed keywords

THYMIDINE KINASE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLONOGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE TRANSFER; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOCYTE COUNT; MIXED LEUKOCYTE CULTURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

HERPES; SIMPLEXVIRUS;

EID: 0033933976     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700186     Document Type: Article

References (27)

1. Barrett AJ. Mechanisms of the graft-versus-leukemia reaction. Stem Cells. 1997;15:248-258.
2. Gale RP. Graft-versus-host disease. Immunol Rev. 1985; 88:193-214.
3. Ferrara JL, Deeg HJ. Graft versus host disease. N Engl J Med. 1991;324:667-674.
4. Kernan NA, Collins NH, Juliano L, Cartagena T, Dupont B, O'Reilly RJ. Clonable T lymphocytes in T-cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood. 1986;68:770-773.
5. Reisner Y, Martelli MF. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunol Today. 1995;16:437-440.
6. Porter DL, Roth MS, McGarigle C, Ferrara JLM, Antin JH. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med. 1994;330:100-106.
7. Lokhorst HM, Schattenberg A, Cornelissen JJ, Thomas LLM, Verdonck LF. Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. Blood. 1997;90:4206-4211.
8. Culver KW, Raw Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 1992;256:1550-1552.
9. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res. 1986;46: 5276-5281.
10. Tiberghien P, Reynolds CW, Keller J, et al. Ganciclovir treatment of herpes simplex thymidine kinase-transduced T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood. 1994;84:1333-1341.
11. Munshi NC, Govindarajan R, Drake R, et al. Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir. Blood. 1997;89:1334-1340.
12. Di Ianni M, Casciari C, Ciurnelli R, et al. Retroviral transfer of herpes simplex virus-thymidine kinase and β-galactosidase genes into U937 cells with bicistronic vector. Leukemia Res. 1997;21:951-959.
13. Varmus H. Retroviruses. Science. 1988;240:1427-1435.
14. Srivastava S, Minowada J. Terminal deoxynucleotidyl transferase activity in a cell line (molt-4) derived from peripheral blood of a patient with acute lymphoblastic leukemia. Biochem Biophys Res Commun. 1973;51:529-535.
15. Chen WF, Wilson A, Scollay R, Shortman K. Limit dilution assay and clonal expansion of all T cells capable of proliferation. J Immunol Methods. 1982;52:307-322.
16. Humeau L, Chabannon C, Firpo MT, et al. Successful reconstitution of human hematopoiesis in the SCID-hu mouse by genetically modified, highly enriched progenitors isolated from fetal liver. Blood. 1997;90:3496-3506.
17. + T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and three-colour flow cytometry. Clin Exp Immunol. 1996;105:517-522.
18. Kolb HJ, Schattenberg A, Goldman JM, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow-grafted patients: European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood. 1995;86:2041-2050.
19. MacKinnon S, Papadopoulos EB, Carabasi MH, et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood. 1995;86:1261-1268.
20. Van Rhee F, Kolb HJ. Donor leukocyte transfusions for leukemic relapse. Curr Opin Hematol. 1995;2:423-430.
21. + donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. Blood. 1998;91:3671-3680.
22. Van Bekkum DW, Kinwel-Bohré EPM. Risk of donor lymphocyte infusions following allogeneic bone marrow transplantation. Exp Hematol 1997;25:478-480.
23. Bonini C, Ferrari G, Verzelletti S, et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science. 1997;276:1719-1724.
24. Tiberghien P, Cahn JY, Brion A, et al. Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: a phase I-II study. Hum Gene Ther. 1997;8:615-624.
25. Fellowes WS, Bunnell BA, Carter CS, et al. Preparation of gene-transduced CD4 syngeneic lymphocytes for clinical anti-HIV therapeutic trial. J Hematother. 1998;7:271. Abstract.
26. Link CJ, Burr RK, Traynor AE, Drobyski WR. Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. Hum Gene Ther. 1998;9:115-134.
27. Aversa F, Tabilio A, Terenzi A, et al. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitors cells to bone marrow inoculum. Blood. 1994;84:3948-3955.